Clinical Trial

A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of the study is to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants with Moderate to Severe Vernal Keratoconjunctivitis
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-05; most recent amendment 2026-04-21.
Status change: Not Yet Recruiting → Recruiting 2026-04-10
Trial Details
NCT Number NCT07169695
Lead Sponsor Laboratoires Thea
Conditions Moderate to Severe Vernal Keratoconjunctivitis
Enrollment 120 participants
Start Date 2026-03-24
Primary Completion 2027-01-21 (estimated)
Study Completion 2027-01-21 (estimated)
Updated on ClinicalTrials.gov 2026-04-22